Oct 8, 2026, 9:35 PM EDT · 18 days ago Retension Pharmaceuticals Announces Pricing of Initial Public Offering
Sep 18, 2026, 6:27 PM EDT · 5 weeks ago Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
Sep 18, 2026, 5:44 PM EDT · 5 weeks ago Hypertension drug developer Retension Pharmaceuticals files for a $58 million IPO